Momenta Pharmaceuticals Inc (MNTA.OQ)

MNTA.OQ on NASDAQ Stock Exchange Global Select Market

5 Oct 2015
Change (% chg)

$0.59 (+3.51%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for MNTA.OQ


Momenta Pharmaceuticals, Inc. (Momenta) is a biotechnology company focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. The Company has three product areas: Complex Generics, Biosimilars and Novel Therapeutics. The Company’s product, a generic version of Lovenox... (more)


Beta: 1.78
Market Cap(Mil.): $1,158.15
Shares Outstanding(Mil.): 68.81
Dividend: --
Yield (%): --


  MNTA.OQ Industry Sector
P/E (TTM): -- 63.85 32.90
EPS (TTM): -1.31 -- --
ROI: -20.28 -0.13 14.19
ROE: -21.55 -0.99 15.12
Search Stocks

UPDATE 2-U.S. appeals court again invalidates Teva's MS drug patent

NEW YORK, June 18 - A U.S. appeals court on Thursday once again invalidated a patent held by Teva Pharmaceutical Industries Ltd on its top-selling multiple sclerosis drug Copaxone, clearing the way for the launch of a cheaper, generic version.

18 Jun 2015

FDA approves first generic version of Teva's MS drug Copaxone

April 16 - Momenta Pharmaceuticals Inc said the U.S. Food and Drug Administration approved the first generic version of Teva Pharmaceuticals Industries Ltd's top-selling multiple sclerosis drug, Copaxone.

16 Apr 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
Provider : Thomson Reuters Stock Report
Provider : New Constructs, LLC
Provider : ValuEngine, Inc.
Provider : Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks